Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

View:
Post by RetailRube on May 12, 2015 12:13pm

Next Pop

Which will provide the pop in the stock price?

  1. Submission of the BLA application in June
  2. FDA announcement whether or not the application has been accepted (no more than 60 days following submission)

And when will they know if they have received exemption from filing fees?
Comment by HighteawithIntrepid on May 12, 2015 1:01pm
RR Logically every time we tick a box the odds of ticking the next box increases so the share price should improve as we close in on the final  approval. However, when we delayed our filing by 90 days we added ,1800,000 to our cash burn more or less so the other side of the coin is only  having enough cash to get to September not December. HT
Comment by RetailRube on May 12, 2015 2:06pm
HT, I don't understand why you say our cash burn increased by $1.8m.  Since our cash burn is salaries, and we have the same number of people no matter when we submit, and revenue is in 2016 at best anyway, how has our cash exhaustion date moved from December to September? Are you sure?
Comment by HighteawithIntrepid on May 12, 2015 2:38pm
RR When we moved the filing date from March 31 to about June 30 we added 90 days everything being equal to our requirements for  cash before a cash inflow event. So if we expected a yes from the FDA after 60 days from March 31 or an acceptance by May 31 that is now August 31. I believe the December FS said we had cash to September. So we need 1.8 million more to be in the same Financial ...more  
Comment by bayoubucks on May 12, 2015 2:42pm
HT, do you work for the government in accounting?
Comment by RetailRube on May 12, 2015 3:03pm
OK, I see the difference in our perspectives.  You assumed we would have cash inflow in 2015 from first customer ship.  I assumed we had to wait until final FDA approval which was always in 2016 (1Q-2016 for a while, then 2Q-2016 on the latest presentation).  In my world, they will run out of cash (still) in 4Q-2015.  The delay in filing the BLA has not changed that.
Comment by HighteawithIntrepid on May 13, 2015 7:53am
RR Under a March filing my expectation was that the September 2015 warrants would be a cash flow event, but now not so much as the acceptance  of the filing is not a given before they expire.
Comment by blartar on May 13, 2015 10:02am
HT   don't concern yourself about the Sept. 2015 warrants. Management loaded up on lots of OPTIONS @ .30-.40  to replace them when they exspire.That probably puts them in the right hands now.   JMHO
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities